Advancements in leukemia management: Bridging diagnosis, prognosis and nanotechnology (Review).

ABSTRACT: Leukemia is a cancer that starts in blood stem cells in the bone marrow. Today, the proper diagnosis and prognosis of leukemia are essential in mitigating the morbidity and mortality associated with this malignancy. The advent of novel biomarkers, particularly those related to minimal residual disease, has paved the way for personalized therapeutic strategies and enables the quantitative assessment of patient responses to treatment regimens. Novel diagnostic and targeted drug delivery may be helpful for the improved management of leukemia. Genetic clinical parameters, such as chromosomal abnormalities, are crucial in diagnosing and guiding treatment decisions. These genetic markers also provide valuable prognostic information, helping to predict patient outcomes and tailor personalized tre

SUBMITTER: Li J 

PROVIDER: S-EPMC11542963 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature